Bioceltix S.A. (WSE:BCX)
Poland
· Delayed Price · Currency is PLN 94.90
+2.50 (2.71%)
Feb 21, 2025, 3:38 PM CET
Bioceltix Market Cap
Bioceltix has a market cap or net worth of 467.82 million as of February 21, 2025. Its market cap has increased by 26.16% in one year.
Market Cap
467.82M
Enterprise Value
430.57M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
94.90
Market Cap Chart
Since November 8, 2021, Bioceltix's market cap has increased from 115.04M to 467.82M, an increase of 306.67%. That is a compound annual growth rate of 53.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 467.82M | 8.45% |
| Dec 30, 2024 | 431.38M | 16.07% |
| Dec 29, 2023 | 371.65M | 179.48% |
| Dec 30, 2022 | 132.98M | -22.49% |
| Dec 30, 2021 | 171.57M | 49.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NEUCA | 3.62B |
| Synektik Spólka Akcyjna | 1.95B |
| Voxel | 1.51B |
| Celon Pharma | 1.25B |
| Selvita | 905.84M |
| Ryvu Therapeutics | 627.71M |
| Centrum Medyczne ENEL-MED | 565.61M |
| Scope Fluidics | 485.76M |